AstraZeneca is planning to expand its operations in Cambridge by adding 1,000 new employees. The expansion includes the construction of a new facility adjacent to its existing global R&D Discovery Centre in the city.
The new development aims to bolster AstraZeneca’s research and development capabilities, supporting its ongoing commitment to innovation in pharmaceuticals and healthcare. The company has not yet disclosed specific timelines for the construction or completion of the new facility but emphasizes its focus on strengthening its presence in the Cambridge biotech hub.
This expansion aligns with AstraZeneca’s broader strategy to enhance its scientific research and accelerate the development of new medicines. Local officials and industry partners have welcomed the news, highlighting the potential economic and scientific benefits for the region. Further details on the project are expected to be announced as planning progresses.